A novel xenograft model of human hepatocellular carcinoma in immunocompetent mice based on the microcarrier-6
- 8 November 2022
- journal article
- research article
- Published by Elsevier in Transplant Immunology
- Vol. 76, 101738
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Heterogeneity of liver cancer and personalized therapyCancer Letters, 2016
- Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer ResearchCancer Discovery, 2014
- Establishing a human renal cell carcinoma tumorgraft platform for preclinical drug testingNature Protocols, 2014
- Systemically delivered measles virus-infected mesenchymal stem cells can evade host immunity to inhibit liver cancer growthJournal of Hepatology, 2013
- Patient-Derived Tumor Xenografts: Transforming Clinical Samples into Mouse ModelsCancer Research, 2013
- A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft ModelsCancer Research, 2013
- A novel mouse model of gastric cancer with human gastric microenvironmentCancer Letters, 2012
- The Promise of Patient-Derived Xenografts: The Best Laid Plans of Mice and MenClinical Cancer Research, 2012
- Patient-derived tumour xenografts as models for oncology drug developmentNature Reviews Clinical Oncology, 2012
- Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient miceNature Protocols, 2009